Skip to main content

Table 2 The Performance of CT Features-based Model, Meso-Esophageal Fat-Based, and Tumor-Based Models for OS Evaluation in Patients with ESCC

From: CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy

Models

C-index (95% CI)

 

Training cohort

Testing cohort

External validation cohort

CT features

0.523 (0.402–0.644)

0.502 (0.392-0612)

0.498 (0.429–0.567)

Meso-esophageal fat

0.688 (0.610–0.765)

0.708 (0.598–0.816)

0.660 (0.540–0.781)

Tumor

0.665 (0.589–0.742)

0.602 (0.465–0.740)

0.524 (0.408–0.640)

p1

0.312

0.077

0.048

p2

0.039

0.002

0.005

  1. Note: p1 was calculated from the comparison between meso-esophageal fat-based models and tumor-based models; p2 was calculated from the comparison between meso-esophageal fat-based models and CT features-based models